rs7661020
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_016599.5(MYOZ2):c.561-139T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 726,368 control chromosomes in the GnomAD database, including 35,571 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_016599.5 intron
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 16Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.274 AC: 41703AN: 151980Hom.: 6241 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.313 AC: 179599AN: 574272Hom.: 29332 AF XY: 0.308 AC XY: 93681AN XY: 304186 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.274 AC: 41722AN: 152096Hom.: 6239 Cov.: 32 AF XY: 0.273 AC XY: 20297AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at